This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Dragonfly Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hemanta Baruah: Innovator in Multispecific Binding Proteins
Introduction
Hemanta Baruah is a notable inventor based in Euless, Texas. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding proteins. His work focuses on innovative therapeutic methods for cancer treatment.
Latest Patents
Hemanta Baruah holds a patent for "Proteins binding NKG2D, CD16 and CLEC12A." This patent describes multispecific binding proteins that interact with the NKG2D receptor, CD16, and CLEC12A. The pharmaceutical compositions derived from these proteins are aimed at providing new therapeutic options for cancer patients.
Career Highlights
Baruah is currently associated with Dragonfly Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective cancer therapies.
Collaborations
Some of his notable coworkers include Gregory P. Chang and Ann F. Cheung, who contribute to the collaborative environment at Dragonfly Therapeutics, Inc.
Conclusion
Hemanta Baruah's innovative work in the field of multispecific binding proteins exemplifies the potential for new cancer treatments. His contributions are paving the way for advancements in therapeutic methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile